Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News Why NeMo Guardrails is becoming the AI policy engine enterprises and governments need in 2025 Find out how NeMo Guardrails is transforming enterprise and sovereign AI compliance strategies with auditable, policy-driven language model control. byPallavi MadhirajuAugust 25, 2025